Edition 4 / December 2020
Welcome to the Quarter 4 (Corden Connect) Newsletter. My name is Will Cashin. I’m Group Chief Quality & Compliance Officer.
2020 has been a challenging year for all of us in our industry but as I speak to you from beautiful Basel, one of the centers of world innovation for pharmaceuticals, I couldn’t be more proud of the efforts our team in Liestal have made in the development of lipid nanoparticles, which is the foundation of a lot of the treatments coming in mRNA.
At the same time, I also want to recognize the work of our colleagues in Italy who throughout the pandemic have ensured uninterrupted supply of essential medicines. It is to their credit that you, our customer, and your patients have experienced uninterrupted supply, even during the most difficult crisis in a generation.
Quality & Compliance at CordenPharma consists of Quality Assurance, Quality Control, Occupational Health & Safety, and Environmental Protection. Our subject matter experts and leaders around the world do our very best to ensure that you, our customer, are served with even more reliable products & services than ever before.
In this quarter’s newsletter, Dr. Iris Ziegler will speak to us about Quality Risk Management (QRM) and Knowledge Management, and Yves Michon will tell us how the CordenPharma facility at Chenôve France has increased supply during the pandemic.
It’s taken a tremendous effort to serve you in 2020, and we look forward to your support and loyalty in 2021.
Stay up to date with the latest thought leadership articles and news from CordenPharma.